Strategic Collaboration Potential sales opportunities through partnership with research-driven biotech and pharma entities. Recent collaboration with aTyr Pharma demonstrates openness to external proteomics services for drug discovery, signaling a prime angle for joint projects and sponsored research.

Target Identification Capitalize on Dualsystems TriCEPS and Flow-TriCEPS capabilities to offer target and off-target identification on living cells, including small molecules. Market to biotech startups and academic labs seeking high-confidence target maps for ligand, protein, and virus interactions.

Membrane Proteomics Niche Position as a specialized service provider for cell membrane target discovery. Emphasize LC-MS/MS based workflows that can de-risk early target validation for customers developing biologics, peptides, or small-molecule therapeutics.

SME Growth Potential Target small to mid-sized biotech companies and research groups with limited proteomics capacity. With a lean team and focused services, offer scalable engagement models, fast turnaround, and bundled packages for recurrent projects.

Digital Outreach Readiness Leverage existing tech stack and channels (LinkedIn, Google Ads, content optimization) to reach decision-makers in academia and industry. Propose thought leadership, case studies, and collaborative grant-ready offerings to convert interest into pilot projects.